Clinical Trials · NCT05016882
Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 698
- Start date
- Aug 2021
- Locations
- 255 sites, 24 countries
- Primary endpoint
- Improvement in liver fibrosis and no worsening of NASH (Yes/No)